Rivopharm (uk) Limited

Rivopharm UK Ltd, based in London, is a small, active pharmaceutical company established 18 years ago. With eight employees and £6.6 million in assets, it operates from a virtual address – a point of note as 31 companies share the same location – and is led by four directors and a single owner, Poli Piero Luigi Umberto. The company has a Google rating of just 1.0 based on two reviews. It regularly imports pharmaceutical products, with 38 months of import activity recorded, the latest in July 2024.

Rivopharm UK Ltd specializes in marketing and supplying quality generic pharmaceutical products through various channels, including wholesale, retail, and secondary care. It sources products from its Swiss site (Rivopharm SA) and collaborates with Developharma for research and development. The company also licenses and markets products from third parties, aiming to drive growth through both in-house development and strategic partnerships. Its website highlights a focus on quality, niche products, and a commitment to customer service.

Financially, Rivopharm UK Ltd presents a mixed picture. Current assets decreased slightly, falling by 1.9% to £6.6 million, while net assets saw a significant boost, climbing 48% to £1.6 million. Bank borrowings increased substantially, rising by 2,400% to £17,000, and cash reserves plummeted 100% to zero – a concerning trend. Creditors decreased by 13%, suggesting improved debt management, and trade debtors fell by 12%. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for agility, but the sharp decline in cash reserves warrants attention. No auditor is mentioned, reflecting its exemption as a small company.

Overall, Rivopharm UK Ltd appears to be navigating a period of change. While its asset base and equity have grown, the depletion of cash reserves suggests a need for careful financial management. The company’s focus on quality pharmaceuticals and strategic partnerships could help sustain its growth, but monitoring its cash flow will be crucial in the coming months.

Registered in England/Wales under the registration number 05986035, with a registered address at EC2N 4AG, England, London, 100 Bishopsgate.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.